The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2023 | Key themes in colorectal cancer at ESMO WCGIC 2023
John Strickler, MD, Duke University, Durham, NC, provides influential highlights from the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023, including results relating to immunotherapy combinations for microsatellite stable colorectal cancer. Furthermore, key updates will be given on targeting KRAS and immunotherapy for upper GI cancers. This interview took place at the ESMO WCGIC 2023 in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
